Abstract
Recent evidence suggests that many tissue kallikreins are implicated in carcinogenesis. Kallikrein 8 (KLK8) plays a role in the physiology of the central nervous system. Kallikrein 7 (KLK7) takes part in skin desquamation. Both show altered expression in ovarian and breast cancer. In this study, we examined the level of mRNA expression of the KLK7 and KLK8 genes in 73 intracranial tumors using qualitative RT-PCR. The results were correlated with clinical and histomorphological variables and patient outcome. The expression of both genes was also examined in the brain cancer cell lines U-251 MG, D54 and SH-SY5Y and the invasive capacity of glioblastoma cells U-251 MG overexpressing hK7 or hK8 was also investigated in an in vitro Matrigel assay. Follow-up analysis revealed that expression of KLK7 mRNA was associated with shorter overall survival (OS) compared to patients with no KLK7 expression, as determined by Cox proportional hazard regression analysis. Overexpression of hK7 protein by cultivated brain tumor cells significantly enhanced the invasive potential in the Matrigel invasion assay, in contrast to cells overexpressing hK8 protein. Our data suggest that hK7 protein overexpression is associated with a more aggressive phenotype in brain cancer cells.
References
Bhattacharjee, A., Richards, W.G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Behesti, J., Bueno, R., Gilette, M., et al. (2001). Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA98, 13790–13795.10.1073/pnas.191502998Search in Google Scholar
Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human kallikreins in cancer. Nat. Rev. Cancer4, 876–890.10.1038/nrc1474Search in Google Scholar
Brattsand, M., Steffansson, K., Lundh, C., Haasum, Y., and Egelrud, T. (2005). A proteolytic cascade of kallikreins in the stratum corneum. J. Invest. Dermatol.124, 198–203.10.1111/j.0022-202X.2004.23547.xSearch in Google Scholar
Cane, S., Bignotti, E., Bellone, S., Palmieri, M., De las Casas, L., Roman, J.J., Pecorelli, S., Cannon, M.J., O'Brien, T., and Santin, A.D. (2004). The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/neuropsin/ovasin) is highly overexpressed in cervical cancer. Am. J. Obstet. Gynecol.190, 60–66.10.1016/j.ajog.2003.07.020Search in Google Scholar
Cox, D.R. (1972). Regression models and life tables. R. Stat. Soc. B.34, 187–202.10.1111/j.2517-6161.1972.tb00899.xSearch in Google Scholar
Del Rosso, M., Fibbi, G., Pucci, M., D'Alesio, S., Del Rosso, A., Magneli, L., and Chiarugi, V. (2002). Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin. Exp. Metast.19, 193–207.10.1023/A:1015531321445Search in Google Scholar
Chung, C.H., Parker, J.S., Karaca, G., Wu, J., Funkhouser, W.K., Moore, D., Butterfoss, D., Xiang, D., Zanation, A., Yin, X., et al. (2004). Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell5, 489–500.10.1016/S1535-6108(04)00112-6Search in Google Scholar
Diamandis, E.P., Yousef, G.M., Luo, L.Y., Magklara, A., and Obiezu, C. (2000). The new kallikrein gene family – implications in carginogenesis. Trends Endocrinol. Metab.11, 54–60.10.1016/S1043-2760(99)00225-8Search in Google Scholar
Diamandis, E.P., Scorilas, A., Kishi, T., Blennow, K., Luo, L.Y., Soosaipillai, A., Rademaker, A.W., and Sjogren, M. (2004). Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. Clin. Biochem.37, 230–237.10.1016/j.clinbiochem.2003.11.012Search in Google Scholar PubMed
Davies, B., Kearns, I.R., Ure, J., Davies, C., and Lathe, R. (2001). Loss of hippocampal serine protease BSP1/neuropsin predisposes to global seizure activity. J. Neurosci.21, 6993–7000.10.1523/JNEUROSCI.21-18-06993.2001Search in Google Scholar
Hansson, L., Strömqvist, M., Bäckman, A., Wallbrandt, P., Carlstein, A., and Egelrud, T. (1994). Cloning, expression and characterization of stratum corneum chymotryptic enzyme. J. Biol. Chem.269, 19420–19426.10.1016/S0021-9258(17)32185-3Search in Google Scholar
He, X.P., Shiosaka, S., and Yoshida, S. (2001). Expression of neuropsin in oligodendrocytes after injury to the CNS. Neurosci. Res.39, 455–462.10.1016/S0168-0102(01)00200-0Search in Google Scholar
Kaplan, E.L. and Meier, P. (1958). Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc.53, 457–481.10.1080/01621459.1958.10501452Search in Google Scholar
Kishi, T., Grass, L., Soosaipillai, A., Scorilas, A., Harbeck, N., Schmalfeldt, B., Dorn, J., Mysliwiec, M., Schmitt, M., and Diamandis, E.P. (2003a). Human kallikrein 8, a novel biomarker for ovarian carcinoma. Cancer Res.63, 2771–2774.Search in Google Scholar
Kishi, T., Grass, L., Soosaipillai, A., Shimizu-Okabe, C., and Diamandis, E.P. (2003b). Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids. Clin. Chem.49, 87–96.10.1373/49.1.87Search in Google Scholar
Kishi, T., Soosaipillai, A., Grass, L., Little, S.P., Johnstone, E.M., and Diamandis, E.P. (2004). Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids. Clin. Chem.50, 709–716.10.1373/clinchem.2003.029538Search in Google Scholar
Kleihues, P. and Cavenee, W.K., eds. (2000). WHO Classification of Tumors (Lyon, France: IARC Press), pp. 6–70.Search in Google Scholar
Kyriakopoulou, L.G., Yousef, G.M., Scorilas, A., Katsaros, D., Massobrio, M., Fracchioli, S., and Diamandis, E. (2003). Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer. Clin. Biochem.36, 135–143.10.1016/S0009-9120(02)00446-0Search in Google Scholar
Landis, S.H., Murray, T., Bolden, S., and Wingo, P.A. (1998). Cancer statistics, 1998. CA Cancer J. Clin.48, 6–29.10.3322/canjclin.48.1.6Search in Google Scholar PubMed
Liaw, L. and Crawford, H.C. (1999). Functions of the extracellular matrix and matrix degrading proteases during tumor progression. Braz. J. Med. Biol. Res.32, 805–812.10.1590/S0100-879X1999000700002Search in Google Scholar PubMed
Lundström, A. and Egelrud, T. (1991). Stratum corneum chymotryptic enzyme: a proteinase which may be generally present in the stratum corneum and with a possible involvement in desquamation. Acta Derm. Venereol.71, 471–474.Search in Google Scholar
Magklara, A., Scorilas, A., Katsaros, D., Massobrio, M., Yousef, G.M., Frachiolli, S., Danese, S., and Diamandis, E.P. (2001). The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin. Cancer Res.7, 806–811.Search in Google Scholar
Matsumoto-Miyai, K., Ninomiya, A., Yamasaki, H., Tamura, H., Nakamura, Y., and Shiosaka, S. (2003). NMDA-dependent proteolysis of presynaptic adhesion molecule L1 in the hippocampus by neuropsin. J. Neurosci.23, 7727–7736.10.1523/JNEUROSCI.23-21-07727.2003Search in Google Scholar
Prezas, P., Arlt, M.J.E., Viktorov, P., Soosaipillai, A., Holzscheiter, L., Schmitt, M., Talieri, M., Diamandis, E.P., Kruger, A., and Magdolen, V. (2006). Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells. Biol. Chem.387, 807–811.10.1515/BC.2006.102Search in Google Scholar PubMed
Rajapakse, S., Ogiwara, K., Takano, N., Moriyama, A., and Takahashi, T. (2005). Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins. FEBS Lett.579, 6879–6884.10.1016/j.febslet.2005.11.039Search in Google Scholar
Roman-Gomez, J., Jimenez-Velasco, A., Agerre, X., Castillejo, J.A., Barrios, M., Andreu, E.J., Prosper, F., Heiniger, A., and Torres, A. (2004). The normal epithelial cell-specific 1 (NES1) gene, a candidate tumor suppressor gene on chromosome 19q13.3-4, is downregulated by hypermethylation in acute lymphoblastic leukemia. Leukemia18, 362–365.Search in Google Scholar
Shimizu-Okabe, C., M. Yousef, G.M., P. Diamandis, E.P., Yoshida, S., Shiosaka, S., and Fahnestock, M. (2001). Expression of the kallikrein gene family in normal and Alzheimer's disease brain. Neuroreport12, 2747–2751.10.1097/00001756-200108280-00031Search in Google Scholar
Spiropoulou, T., Ferekidou, L., Angelopoulou, K., Stathopoulou, A., Talieri, M., and Lianidou, E.S. (2004). Effect of antineoplastic agents on the expression of human telomerase reverse transcriptase β plus transcript in MCF-7 cells. Clin. Biochem.37, 299–304.10.1016/j.clinbiochem.2003.12.008Search in Google Scholar
Talieri, M., Diamandis, E.P., Gourgiotis, D., Mathioudaki, K., and Scorilas, A. (2004). Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma. Thromb. Haemost.91, 180–186.10.1160/TH03-05-0261Search in Google Scholar
Yoshida, S., Taniguchi, M., Hirata, A., and Shiosaka, S. (1998). Sequence analysis and expression of human neuropsin cDNA and gene. Gene213, 9–16.10.1016/S0378-1119(98)00232-7Search in Google Scholar
Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein family: structure, function and association to disease. Endocrine Rev.22, 184–204.Search in Google Scholar
Yousef, G.M., Scorilas, A., Magklara, A., Soosaipillai, A., and Diamandis, E.P. (2000). The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme, is a new member of the human kallikrein gene family – genomic characterization, mapping, tissue expression, and hormonal regulation. Gene254, 119–128.10.1016/S0378-1119(00)00280-8Search in Google Scholar
Yousef, G.M., Kishi, T., and Diamandis, E.P. (2003). Role of kallikrein enzymes in the central nervous system. Clin. Chim. Acta329, 1–8.10.1016/S0009-8981(03)00004-4Search in Google Scholar
Yousef, G.M. Borgono, C.A., Popalis, S., Yacoub, G.M., Polymeris, M.E., Soosaipillai, A., and Diamandis, E.P. (2004). In silico analysis of kallikrein gene expression in pancreatic and colon cancers. Anticancer Res.24, 43–52.Search in Google Scholar
©2006 by Walter de Gruyter Berlin New York
